FRAGMIN

Pfizer Canada Ulc🇨🇦 Health Canada

Approval Id: 55d9f6f2a86a800d
Drug Approval Canada Name: FRAGMIN
Product Name: FRAGMIN
Status: Marketed
Status Date: 2020-06-08
Original Market Date: 2020-06-08
Din: 02494582
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous , Subcutaneous
Schedule: Prescription
Ahfs: 20:12.04.16
Atc Original: B01AB04 DALTEPARIN
Atc Name: b 01 ab 04
Aig Number: 0126861002
Company Name: Pfizer Canada Ulc
Company Address: 17300 Trans-Canada Highway, Kirkland, Quebec, Canada, H9J 2M5
Company Detail Path: /organization/pfizer-canada-ulc

DALTEPARIN SODIUM

16500 UNIT / 0.66 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

55d9f6f2a86a800d

Type

Standard